EPMA Journal

, Volume 10, Issue 1, pp 51–64 | Cite as

Review of herbal medications with the potential to cause bleeding: dental implications, and risk prediction and prevention avenues

  • Worku AbebeEmail author


Medicinal plant products have been used in health care since time immemorial. During the past three decades, the use of herbal supplements has been on the rise in the USA. A number of these products have been shown to possess the potential to interfere with blood clotting. This paper is a review of blood-thinning herbal supplements commonly used in the USA, accompanied by discussion of the dental implications of their use along with suggestions for prediction and prevention of the risk of bleeding. Twenty herbal supplements belonging to four pharmacological groups are identified and reviewed. While the majority (45%) of the supplements reviewed possesses antiplatelet properties, the remaining are dispersed among anticoagulant (15%), a combination of antiplatelet and anticoagulant (15%), and other diverse groups (25%). The literature reveals that most of the available information on blood-thinning herbs is based on in vitro experiments, animal studies, and individual clinical case reports. Some herbal effects are also speculated based on theoretical grounds. These observations, together with the deficiency of the law regulating herbal supplements, indicate limitations of the literature and the regulatory mechanisms related to these products, further implying the need for additional research and improved regulation. While emphasizing the dental implications of the findings reported in the literature, suggestions were made for prediction and prevention of the risk of bleeding caused by herbal medications, based on the concepts of predictive, preventive, and personalized medicine.


Predictive preventive personalized medicine Vascular injury Risk factors Bleeding Blood-thinning Coagulation pathways Herbal supplements Aloe Ginger Ginkgo Garlic Green tea Grapefruit Ginseng Oregano Dentistry Obesity Inflammation Diabetes Cancer Infections Individualized patient profile 


Compliance with ethical standards

Conflict of interest

The author declares no conflict of interest in relation to the present work.

Informed consent

Patients have not been involved in relation to this work.

Human and animal rights

No experiments have been performed involving humans or animals in relation to this work.


  1. 1.
    Abebe W. An overview of herbal supplement utilization with particular emphasis on possible interactions with dental drugs and oral manifestations. J Dent Hyg. 2003;77:37–6.Google Scholar
  2. 2.
    Kapinova A, Stefanicka P, Kubatka P, Zubor P, Uramova S, Kello M, et al. Are plant-based functional foods better choice against cancer than single phytochemicals? A critical review of current breast cancer research. Biomed Pharmacother. 2017;96:1465–77.CrossRefGoogle Scholar
  3. 3.
    Hao P, Jiang F, Cheng J, Ma L, Zhang Y, Zhao Y. Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms. J Am Coll Cardiol. 2017;69:2952–66.CrossRefGoogle Scholar
  4. 4.
    Dubey SK, Singhvi G, Krishna KV, Agnihotri T, Saha RN, Gupta G. Herbal medicines in neurodegenerative disorders: an evolutionary approach through novel drug delivery system. J Environ Pathol Toxicol Oncol. 2018;37:199–208.CrossRefGoogle Scholar
  5. 5.
    Martel J, Ojcius DM, Chang CJ, Lin CS, Lu CC, Ko YF, et al. Anti-obesogenic and antidiabetic effects of plants and mushrooms. Nat Rev Endocrinol. 2017;13:149–60.CrossRefGoogle Scholar
  6. 6.
    Abebe W. Herbal supplements. Any relevancy to dental practice? N Y State Dent J. 2002;68:26–30.Google Scholar
  7. 7.
    Abebe A, Herman W, Konzelman J. Herbal supplement use among adult dental patients in a USA dental school clinic: prevalence, patient demographics, and clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:320–5.CrossRefGoogle Scholar
  8. 8.
    Ge B, Zhang Z, Zuo Z. Updates on the clinical evidenced herb-warfarin interactions. Evid Based Complement Alternat Med. 2014;2014:957362–18. Scholar
  9. 9.
    Marriotti AJ. Use of herbs and herbal dietary supplements in dentistry. In: Dowd FJ, Johnson BS, Marriotti AJ, editors. Pharmacology and therapeutics for dentistry. 7th ed. St Louis, Missouri: Elsevier; 2017. p. 642–7.CrossRefGoogle Scholar
  10. 10.
    Smith T, Kawa K, Eckl V, Morton C, Stredney R. US sales of herbal supplements increase by 7.7% in 2016. Herbal Gram. 2017;115:56–64.Google Scholar
  11. 11.
    National Institute of Health, Office of Dietary Supplements. Accessed 29 Sept 2018.
  12. 12.
    Kennedy J, Wang CC, Wu CH. Patient disclosure about herb and supplement use among adults in the US. Evid Based Complement Alternat Med. 2008;5:451–6.CrossRefGoogle Scholar
  13. 13.
    Barnes PM, Griner EP, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States 2002. Adv Data Vital Health Stat. 34; 2004. pp. 1–20.Google Scholar
  14. 14.
    Rashrash M, Schommer JC, Brown LM. Prevalence and predictors of herbal medicine use among adults in the United States. J Patient Exp. 2017;4:108–13.CrossRefGoogle Scholar
  15. 15.
    Dergal JM, Gold JL, Laxer DA, Lee MS, Binns MA, Lanctôt KL. Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging. 2002;19:879–86.CrossRefGoogle Scholar
  16. 16.
    Tsen LC, Segal S, Pothied M, Bader AM. Alternative medicine use in presurgical patients. Anesthesiology. 2000;93:148–51.CrossRefGoogle Scholar
  17. 17.
    Sparreboom A, Cox MC, Acharya MR. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol. 2004;22:2489–503.CrossRefGoogle Scholar
  18. 18.
    Rogers EA, Gough JE, Brewer KL. Are emergency department patients at risk for herb-drug interactions? Acad Emerg Med. 2001;8:932–44.CrossRefGoogle Scholar
  19. 19.
    Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M. Trends in alternative medicine use in the United States, 1990-97: results of a follow-up national survey. JAMA. 1998;280:1569–75.CrossRefGoogle Scholar
  20. 20.
    Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther. 2002;27:391–401.CrossRefGoogle Scholar
  21. 21.
    Hall JE. Hemostasis and blood coagulation. In: Guyton & Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016. p. 483–93.Google Scholar
  22. 22.
    Brenner GM, Stevens CW. Pharmacology. 3rd ed. Philadelphia, PA: Saunders; 2010. p. 169–78.CrossRefGoogle Scholar
  23. 23.
    Spolarich AE, Andrews L. An examination of the bleeding complications associated with herbal supplements, antiplatelet and anticoagulant medications. J Dent Hyg. 2007;81:1–22.Google Scholar
  24. 24.
    Abebe W. Herbal supplements having the potential to interfere with blood clotting. GDA Action. 2003;22:23–6.Google Scholar
  25. 25.
    Abebe W. Herbal supplements may require modifications of dental treatments. Dent Today. 2009;28:136–47.Google Scholar
  26. 26.
    PDR. PDR for Herbal Medicines. 4th ed. Montvale, NJ: Thomson Healthcare Inc.; 2007.Google Scholar
  27. 27.
    The Review of Natural Products, 7th ed. Wolters Kluwer Health, St. Louis, Missouri; 2012.Google Scholar
  28. 28.
    Leung AY, Foster S. Encyclopedia of common natural ingredients used in food, drugs and cosmetics. New York, NY: J Willey and Sons; 1990.Google Scholar
  29. 29.
    Henry R. An update of review of aleo vera. Cosmetics and Toiletries. 1979;94:42–9.Google Scholar
  30. 30.
    Lee A, Chui PT, Aun CS, Gin T, Leau A. Possible interactions between sevolflurane and aloe vera. Ann Pharmacother. 2004;38:1651–4.CrossRefGoogle Scholar
  31. 31.
    Yang C, Li L, Yang L, Lǚ H, Wang S, Sun G. Anti-obesity and hypolipidemic effects of garlic oil and onion oil in rats fed a high-fat diet. Nutr Metab (Lond). 2018;15:43.CrossRefGoogle Scholar
  32. 32.
    Vaes LPJ, Chyka RA. Interactions of warfarin with garlic, ginger, ginkgo or ginseng: nature of the evidence. Ann Pharmacother. 2000;34:478–82.CrossRefGoogle Scholar
  33. 33.
    Bordia A. Effect of garlic on human platelet aggregation in vitro. Atherosclerosis. 1978;30:355–60.CrossRefGoogle Scholar
  34. 34.
    Rose KD, Croissant PD, Parliament CF, Levin MP. Spontaneous spinal epidural hemaroma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery. 1990;26:880–2.CrossRefGoogle Scholar
  35. 35.
    Burnham BE. Garlic as a possible risk for postoperative bleeding. Plast Reconstr Surg. 1995;95:213–9.CrossRefGoogle Scholar
  36. 36.
    Heras N, Muñoz MV, Fernández BM, Ballesteros S, Farré AL, Roso BR, et al. Molecular factors involved in the hypolipidemic- and insulin-sensitizing effects of a ginger (Zingiber officinaleRoscoe) extract in rats fed a high-fat diet. Appl Physiol Nutr Metab. 2017;42(2):209–15.CrossRefGoogle Scholar
  37. 37.
    Srivastava KC. Aqueous extract of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism. Biomedical Biochimcal Acta. 1984;43:335–46.Google Scholar
  38. 38.
    Bordia A, Verma SK, Srivastavs CK. Effect of ginger and fenugreek on blood lipids, blood sugar and platelet aggregation in patients with coronary heart disease. Prostaglandin, Leukot Essent Fatty Acids. 1977;56:379–84.CrossRefGoogle Scholar
  39. 39.
    Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000;57:221–7.CrossRefGoogle Scholar
  40. 40.
    Lininger SW, Gaby AR, Batz F, Yarnell E, Brown DJ, Constantine G. A-Z guide to drug-herb–vitamin interactions. Rockline, CA: Prima Publishing; 1999.Google Scholar
  41. 41.
    Miller LG. Herbal medicinals: selected clinical considerations focusing on potential herb–drug interactions. Arch Intern Med. 1998;158:2200–11.CrossRefGoogle Scholar
  42. 42.
    Chung KF, Dent G, McCuster M, Guinot P, Page CP, Barnes PJ. Effect of a ginkgolide mixture (BN 52063) in antagonizing skin and platelet responses to platelet activating factor in man. Lancet. 1987;1:248–51.CrossRefGoogle Scholar
  43. 43.
    Rosenblatt M, Mindel J. Spontaneous hyperema associated with ingestion of Ginkgo biloba extract. N Engl J Med. 1997;336:1108–15.CrossRefGoogle Scholar
  44. 44.
    Liapina LA. A comparative study of the action of the hemostatic system of extracts from the flowers and seeds of the meadowaweet (Filipendula ulmaria L maxim). Izv Akad Nauk Series Biol. 1998;4:625–8.Google Scholar
  45. 45.
    Rajani RS, Singh P, Singh LV. Apoptotic and immunosuppressive effects of turmeric paste on 7, 12 di methyl benz (a) anthracene induced skin tumor model of wistar rat. Nutr Cancer. 2017;69:1245–55.CrossRefGoogle Scholar
  46. 46.
    Srivastavs CK, Bordia A, Verma SK. Cucumin, a major component of food spice, turmeric, inhibits aggregation of and alters ecosanoid metabolism in human blood platelets. Prostaglandin Leukot Essent Fatty Acids. 2000;52:223–7.CrossRefGoogle Scholar
  47. 47.
    Furst DE, Sarkissian E, Blocka K. Serum concentration of salicylate and naproxen during concurrent therapy in patients with rheumatoid arthritis. Arthritis Rheum. 1998;30:1157–61.CrossRefGoogle Scholar
  48. 48.
    Segal R, Pilote L. Research warfarin interaction with Matricaria chamomilla. Can Med Assoc J. 2006;174:1281–2.CrossRefGoogle Scholar
  49. 49.
    Page RL, Lawrence JD. Potentiation of warfarin by dong quai. Pharmacotherapy. 1999;19:870–6.CrossRefGoogle Scholar
  50. 50.
    Qi-bing M, Jing-Yi T, Bo C. Advances in the pharmacological studies of Radix Angelica sincensis (OLIV) Diels (Chinese danggui). Chin Med J. 1991;104:776–81.Google Scholar
  51. 51.
    Yin ZZ. The effect of dong quai (Angelica sinsis) and its ingredient ferulic acid on rat platelet aggregation and release of 5-HT. Acta Pharm Sin. 1980;15:321–30.Google Scholar
  52. 52.
    Ko FN, Wu TS, Liou MJ, Huang TF, Teng CM. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens. Thromb Haemost. 1989;62:996–9.CrossRefGoogle Scholar
  53. 53.
    Junlie T, Huaijiun H. Effect of radix angelicae sinensis on hemorreology in patients with acute ischemic stroke. J Tradit Chin Med. 1984;4:225–8.Google Scholar
  54. 54.
    De La Guz JP, Martin-Ramero M, Carmona A. Effect of evening primrose oil on platelet aggregation in rabbits fed on atherogenic diet. Thromb Res. 1997;87:141–9.CrossRefGoogle Scholar
  55. 55.
    Kuo SC, Teng CM, Lee JG, Ko FN, Chen SC, Wu TS. Anti-platelet components in planax ginseng. Planta Med. 1990;56:164–7.CrossRefGoogle Scholar
  56. 56.
    Kim H, Lee HJ, Kim DJ, Kim TM, Moon HS, Choi H. Panax ginseng exerts antiproliferative effects on rat hepatocarcinogenesis. Nutr Res. 2013;33:753–60.CrossRefGoogle Scholar
  57. 57.
    Park HJ, Lee JH, Song YB, Park KH. Effects of dietary supplementation of lipophilic fraction from Panax giseng on cGMP and cAMP in rat platelets and on blood coagulation. Biol Pharm Bull. 1996;19:1434–9.CrossRefGoogle Scholar
  58. 58.
    Greenspan EM. Ginseng and vaginal bleeding. JAMA. 1993;249:2018–22.CrossRefGoogle Scholar
  59. 59.
    Hopkins MP, Androff L, Benninghoff AS. Ginseng face cream and unexplained vaginal bleeding. Am J Obstet Gynecol. 1988;159:1121–4.CrossRefGoogle Scholar
  60. 60.
    Guo LQ, Yamazoe Y. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Acta Pharmacol Sin. 2004;25:129–36.Google Scholar
  61. 61.
    Hao X, Xiao H, Ju J, Lee MJ, Lambert JD, Yang CS. Green tea polyphenols inhibit colorectal tumorigenesis in azoxymethane-treated f344 rats. Nutr Cancer. 2017;69:623–31.CrossRefGoogle Scholar
  62. 62.
    Nakamura M, Miura S, Takagaki A, Nanjo F. Hypolipidemic effects of crude green tea polysaccharide on rats, and structural features of tea polysaccharides isolated from the crude polysaccharide. Int J Food Sci Nutr. 2017;68:321–30.CrossRefGoogle Scholar
  63. 63.
    Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea. Ann Pharmacother. 1999;33:426–8.CrossRefGoogle Scholar
  64. 64.
    Kubatka P, Kello M, Kajo K, Kruzliak P, Výbohová D, Mojžiš J, et al. Oregano demonstrates distinct tumor-suppressive effects in the breast carcinoma model. Eur J Nutr. 2017;56:1303–16.CrossRefGoogle Scholar
  65. 65.
    Waldron E. Natural supplements, herbs, vitamins, and food: do some prevent blood clots? Clot connect. Accessed 19 Sept 2018.
  66. 66.
    Cheema P, El-Mefty O, Jazieh AR. Intraoperative hemorrhage associated with the use of extract of saw palmetto herb: a case report and review of literature. J Intern Med. 2001;250:167–9.CrossRefGoogle Scholar
  67. 67.
    Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, et al. Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016. EPMA J. 2016;7:23.CrossRefGoogle Scholar

Copyright information

© European Association for Predictive, Preventive and Personalised Medicine (EPMA) 2019

Authors and Affiliations

  1. 1.Department of Oral Biology and Diagnostic Sciences, Dental College of GeorgiaAugusta UniversityAugustaUSA

Personalised recommendations